Demographic and health characteristics of 3,4-methylenedioxymethamphetamine users (MDMA, ecstasy)

被引:1
|
作者
Wieckiewicz, Gniewko [1 ]
Danel, Dariusz [2 ]
Piegza, Magdalena [1 ]
Gorczyca, Piotr [1 ]
Pudlo, Robert [1 ]
机构
[1] Slaski Uniwersytet Med Katowicach, Wydzial Nauk Med Zabrze, Katedra & Oddzial Klin Psychiat, Ul Pyskowicka 49, PL-42612 Katowice, Poland
[2] Polish Acad Sci, Inst Immunol & Terapii Doswiadczalnej Ludwika Hir, Poznan, Poland
关键词
HADS; MDMA; GHQ-28; SUBJECTIVE EXPERIENCES; CARE;
D O I
10.12740/PP/OnlineFirst/134317
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Aim. MDMA is one of the most commonly used drugs in the world. Clinical studies are currently being conducted around the world on the use of this substance in the treatment of PTSD and alcoholism. However, little demographic information is available on users who use the substance for non-medical purposes. The aim of the study was to determine basic demographic and health characteristics with validated tools. Method. The authors prepared an original questionnaire on the demography of MDMA users and combined it with the General Health Questionnaire-28 (GHQ-28) and the Hospital Anxiety and Depression Scale (HADS). The survey was sent to Polish MDMA users via the Internet. Results. 304 responses were received from people over 18 years of age. MDMA is widespread among young adults, in many different places of residence and regardless of gender. The users take MDMA in both pill and crystal form and very rarely test drugs bought from a dealer. Most users feel that MDMA has had a good impact on their lives. Conclusions. MDMA is rarely used as the only psychoactive substance. MDMA users rate their health higher than people using other psychoactive substances.
引用
收藏
页码:1109 / 1130
页数:22
相关论文
共 50 条
  • [41] Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment
    Bhattachary, S
    Powell, JH
    PSYCHOLOGICAL MEDICINE, 2001, 31 (04) : 647 - 658
  • [42] The hyperthermia mediated by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) is sensitive to sex differences
    Wyeth, Richard P.
    Mills, Edward M.
    Ullman, Alison
    Kenaston, M. Alexander
    Burwell, Johanna
    Sprague, Jon E.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2009, 235 (01) : 33 - 38
  • [43] MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: The neuropsychobiological implications of taking it at dances and raves
    Parrott, AC
    NEUROPSYCHOBIOLOGY, 2004, 50 (04) : 329 - 335
  • [44] EFFECTS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE ( MDMA, 'ECSTASY') ON ARGININE VASOPRESSIN IN HEALTHY VOLUNTEERS
    Baggott, M. J.
    Garrison, K.
    Galloway, G. P.
    Mendelson, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S37 - S37
  • [45] Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat
    Upreti, Vijay V.
    Eddington, Natalie D.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (04) : 1593 - 1605
  • [46] Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of Ecstasy
    Kamboj, Sunjeev K.
    Wallden, Ylva S. E.
    Falconer, Caroline J.
    Alotaibi, Majdah Raji
    Blagbrough, Ian S.
    Husbands, Stephen M.
    Freeman, Tom P.
    MINDFULNESS, 2018, 9 (04) : 1134 - 1145
  • [47] Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of Ecstasy
    Sunjeev K. Kamboj
    Ylva S. E. Walldén
    Caroline J. Falconer
    Majdah Raji Alotaibi
    Ian S. Blagbrough
    Stephen M. Husbands
    Tom P. Freeman
    Mindfulness, 2018, 9 : 1134 - 1145
  • [48] EFFECTS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, 'ECSTASY') ON ARGININE VASOPRESSIN IN HEALTHY VOLUNTEERS.
    Baggott, M. J.
    Garrison, K.
    Galloway, G. P.
    Mendelson, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S3 - S3
  • [49] Changes in gene expression induced by prenatal 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) exposure
    Lyles, J
    Cai, NS
    Cadet, JL
    FASEB JOURNAL, 2003, 17 (05): : A1213 - A1213
  • [50] Morphological adaptations in the brain motive circuit induced by 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)
    Ball, Kevin
    FASEB JOURNAL, 2010, 24